These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11129116

  • 41. HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis.
    Jenkins D, Penny MA, Fletcher JA, Jacobs KH, Mijovic CH, Franklyn JA, Sheppard MC.
    Clin Endocrinol (Oxf); 1992 Aug; 37(2):141-5. PubMed ID: 1356664
    [Abstract] [Full Text] [Related]

  • 42. The association of goitrous autoimmune thyroiditis with HLA-DR5.
    Farid NR, Sampson L, Moens H, Barnard JM.
    Tissue Antigens; 1981 Mar; 17(3):265-8. PubMed ID: 6947505
    [Abstract] [Full Text] [Related]

  • 43. H2E-derived Ealpha52-68 peptide presented by H2Ab interferes with clonal deletion of autoreactive T cells in autoimmune thyroiditis.
    Brown NK, McCormick DJ, David CS, Kong YC.
    J Immunol; 2008 May 15; 180(10):7039-46. PubMed ID: 18453626
    [Abstract] [Full Text] [Related]

  • 44. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis.
    Raju R, Zhan WZ, Karachunski P, Conti-Fine B, Sieck GC, David C.
    J Immunol; 1998 May 01; 160(9):4169-74. PubMed ID: 9574516
    [Abstract] [Full Text] [Related]

  • 45. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice.
    Abraham RS, Kudva YC, Wilson SB, Strominger JL, David CS.
    Diabetes; 2000 Apr 01; 49(4):548-54. PubMed ID: 10871191
    [Abstract] [Full Text] [Related]

  • 46. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
    Wen L, Chen NY, Tang J, Sherwin R, Wong FS.
    J Clin Invest; 2001 Apr 01; 107(7):871-80. PubMed ID: 11285306
    [Abstract] [Full Text] [Related]

  • 47. HLA-DQ polymorphism influences progression of demyelination and neurologic deficits in a viral model of multiple sclerosis.
    Pavelko KD, Drescher KM, McGavern DB, David CS, Rodriguez M.
    Mol Cell Neurosci; 2000 Jun 01; 15(6):495-509. PubMed ID: 10860577
    [Abstract] [Full Text] [Related]

  • 48. Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M.
    Rajagopalan G, Smart MK, Cheng S, Krco CJ, Johnson KL, David CS.
    Tissue Antigens; 2003 Aug 01; 62(2):149-61. PubMed ID: 12889995
    [Abstract] [Full Text] [Related]

  • 49. Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.
    Kong YC, Jacob JB, Flynn JC, Elliott BE, Wei WZ.
    Autoimmun Rev; 2009 Sep 01; 9(1):28-33. PubMed ID: 19254781
    [Abstract] [Full Text] [Related]

  • 50. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response.
    Fugger L, Michie SA, Rulifson I, Lock CB, McDevitt GS.
    Proc Natl Acad Sci U S A; 1994 Jun 21; 91(13):6151-5. PubMed ID: 8016129
    [Abstract] [Full Text] [Related]

  • 51. Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis: role of MHC class II.
    Wan Q, Motte RW, McCormick DJ, Fuller BE, Giraldo AA, David CS, Kong YM.
    Clin Immunol Immunopathol; 1997 Nov 21; 85(2):187-94. PubMed ID: 9344702
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
    Sanjeevi CB, Lybrand TP, Landin-Olsson M, Kockum I, Dahlquist G, Hagopian WA, Palmer JP, Lernmark A.
    Tissue Antigens; 1994 Aug 21; 44(2):110-9. PubMed ID: 7817375
    [Abstract] [Full Text] [Related]

  • 54. Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis.
    Das P, Drescher KM, Geluk A, Bradley DS, Rodriguez M, David CS.
    Hum Immunol; 2000 Mar 21; 61(3):279-89. PubMed ID: 10689117
    [Abstract] [Full Text] [Related]

  • 55. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice.
    Khare M, Mangalam A, Rodriguez M, David CS.
    J Neuroimmunol; 2005 Dec 21; 169(1-2):1-12. PubMed ID: 16194572
    [Abstract] [Full Text] [Related]

  • 56. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes?
    Skarsvåg S, Hansen KE, Holst A, Moen T.
    Tissue Antigens; 1992 Sep 21; 40(3):128-33. PubMed ID: 1440567
    [Abstract] [Full Text] [Related]

  • 57. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice.
    Raju R, Munn SR, David CS.
    Hum Immunol; 1997 Nov 21; 58(1):21-9. PubMed ID: 9438206
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Typing for major histocompatibility complex class II antigens in thyroid tissue blocks: association of Hashimoto's thyroiditis with HLA-DQA0301 and DQB0201 alleles.
    Shi Y, Zou M, Robb D, Farid NR.
    J Clin Endocrinol Metab; 1992 Sep 21; 75(3):943-6. PubMed ID: 1517390
    [Abstract] [Full Text] [Related]

  • 60. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T, Yamamoto K, Fukui Y, Fukuda Y, Dohi K, Sasazuki T.
    J Immunol; 1997 Oct 15; 159(8):3717-22. PubMed ID: 9378957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.